Evidence map›Paper›PMID 34426906›Full record

ArticleJournal of clinical immunology2022

Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection.

Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, FJDM study group, Darragh Duffy, Isabelle Melki, Brigitte Bader-Meunier, FJDM Study group

Erratum issuedOpen access · bronzeAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Mathieu Paul Rodero *Chimie & Biologie, Modélisation et Immunologie pour la Thérapie (CBMIT), Université Paris Descartes, CNRS, UMR8601, Paris, France.ORCID http://orcid.org/0000-0002-1300-0187
Stéphane Pelleau *Infectious Diseases Epidemiology and Analytics Unit, Department of Global Health, Institut Pasteur, Paris, France.
Anne Welfringer-MorinDepartment of Dermatology, Université de Paris AP-HP-5, Necker-Enfants Malades Hospital, Paris, France.
FJDM study group
Darragh DuffyTranslational Immunology Lab, Institut, Pasteur, Paris, France.
Isabelle MelkiLaboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris University, Paris, France.
Brigitte Bader-MeunierDepartment of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France. brigitte.bader-meunier@aphp.fr.
FJDM Study group
Hôpital Necker-Enfants Malades · FRBipar · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

agence nationale de la recherche CorPopImmagence nationale de la recherche CoVarImm
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAsymptomatic InfectionsChildCOVID-19COVID-19 Drug TreatmentDermatomyositisFemaleHumansImmunoglobulin GImmunoglobulin MInflammationRecurrenceImmunoglobulin GImmunoglobulin M

Identifiers

PMID34426906
PMCPMC8382211
OpenAlexW3196022979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.